Cure My Disease

Don't miss your cure!

 Log in / Sign up

Robot could let stroke patients rehab their hands at home without a therapist

NCT ID NCT06057129

NEW Symptom relief Sponsor: Swiss Federal Institute of Technology Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 21, 2026 · Last updated Sep 21, 2026

Summary

Researchers are testing whether stroke patients can safely use a hand rehabilitation robot called ReHandyBot on their own, first in a clinic and then at home. The study enrolls 15 adults who recently had a stroke and have hand weakness. Participants learn to use the robot with a therapist, then take it home to train independently. The goal is to see how much extra therapy they do, whether the device is easy to use, and whether any problems occur.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ReHandyBot, a robotic hand rehabilitation device used for unsupervised therapy at home after stroke
What this could lead to
If it works, stroke survivors could add extra hand therapy sessions at home on their own, potentially improving hand function without needing a therapist present for every session.
What could go wrong
This is a small, early feasibility study with 15 participants, so it cannot prove that unsupervised robot therapy improves recovery. Some patients may find the device hard to use alone, and there could be safety issues or technical problems at home.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

15 people

The number who actually took part.

Started

Nov 2023

Finished

May 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 90 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Informed Consent signed by the subject; * female and male patients between 18 and 90 years old; * acute/subacute stroke (recruitment within 12 weeks from stroke onset); * pre-stroke modified Rankin score ≤ 1; * National Institutes of Health Stroke Scale (NIHSS) ≥ 1 in at least one of the items regarding motor functions, sensory functions and ataxia; * possibility (e.g., enough space) to set up the ReHandyBot at home. Exclusion Criteria: * modified Ashworth Scale \> 2 for one or more of the following muscles: shoulder adductors, forearm pronator and supinator, flexors and extensors of elbow, wrist and fingers; * moderate to severe aphasia: Goodglass-Kaplan's scale \< 3; * moderate to severe cognitive deficits: levels of cognitive functioning-revised (LCF-R) \< 9; * functional impairment of the upper limb due to other pathologies; * severe pain in the affected arm: visual analogue scale for pain (VASp) ≥ 5; * other pathologies which may interfere with the study; * pacemakers and other active implants; * after discharge the patient will go to an assisted living facility (e.g., care home).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Stroke are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Stroke

Contacts and locations

Locations

  • Clinica Hildebrand Centro di riabiliazione Brissago

    Brissago, Canton Ticino, 6614, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.